Clinical Trial Update: Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating a rifapentine-based regimen to shorten treatment for drug-susceptible pulmonary tuberculosis, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Drugs mentioned

• rifapentine-based regimen (rifapentine-based regimen)

Snippet

Sponsor: Huashan Hospital | Conditions: Tuberculosis, Pulmonary | Phase 2, Phase 3 | Status: RECRUITING